Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the underwriter of ea
In a report released today, David Lewis from Morgan Stanley maintained a Buy rating on Nevro Crop (NVRO), with a price target of $113.00. The company's
In a report released today, David Lewis from Morgan Stanley maintained a Buy rating on Nevro Crop (NVRO – Research
Nevro (NVRO) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Nevro (NVRO) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Franklin Resources Inc. cut its stake in Nevro Corp (NYSE:NVRO) by 11.6% in the 4th quarter, HoldingsChannel reports. The fund owned 1,332,644 shares of the medical equipment provider’s stock after

Walgreens, Shopify fall; Occidental, Nevro rise

09:05pm, Thursday, 02'nd Apr 2020
NEW YORK (AP) — Stocks that moved heavily or traded substantially on Thursday: Walgreens Boots Alliance Inc., down $2.71 to $40.32. The pharmacy chain warned investors that it can't accurately asses

Walgreens, Shopify fall; Occidental, Nevro rise

09:04pm, Thursday, 02'nd Apr 2020
NEW YORK (AP) — Stocks that moved heavily or traded substantially on Thursday: Walgreens Boots Alliance Inc., down $2.71 to $40.32. The pharmacy chain warned investors that it can't accurately asses
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Merck & Company (MRK), PerkinElmer (PKI) and Nevro
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Merck & Company ( MRK – Research Report ), PerkinElmer ( PKI – Research Report ) and Nevro Crop ( N

LK, CCL among premarket losers

01:16pm, Thursday, 02'nd Apr 2020
Luckin Coffee (NASDAQ:LK) -84% on fraud finding.Golar LNG Partners (NASDAQ:GMLP) -55% on dividend cut.Safe-T Group (NASDAQ:SFET) -28% after pricing direct offering.Dynatronics (NASDAQ:DYNT) -22%�
Nevro (NYSE:NVRO) has priced its public offerings of ~1.6M common shares at $84.00 per share for gross proceeds of ~$136.5M and $165M 2.75% convertible senior notes due 2025.Underwriters' over-allotm
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE